Medical device company AngioDynamics Inc (NASDAQ:ANGO) said on Tuesday that Michael C. Greiner plans to step down as its executive vice president and chief financial officer (CFO).
In conjunction with the change, the company's senior vice president and general counsel Stephen A. Trowbridge will assume the role of interim chief financial officer in addition to his current responsibilities.
However, Greiner will remain with the company to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and has initiated a process to determine a permanent successor.
Additionally, the company is reaffirming its previously issued financial guidance for fiscal year 2020.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project